Loading...
Loading...
Among the 8 tracked institutional investors we monitor, HALO (HALOZYME THERAPEUTICS INC) is held with a combined value of $2.09B across 31,787,885 shares. The largest holder is BlackRock, Inc. with a position worth $857.32M (0.01% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$2.09B
Total Shares Held
31,787,885
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $857.32M | 0.01% | +0.8% |
| 2 | VANGUARD GROUP INC | $778.45M | 0.01% | New |
| 3 | STATE STREET CORP | $319.13M | 0.01% | -3.6% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $47.30M | 0.07% | +30.1% |
| 5 | Bridgewater Associates, LP | $33.05M | 0.15% | -8.9% |
| 6 | MILLENNIUM MANAGEMENT LLC | $30.46M | 0.01% | -68.9% |
| 7 | CITADEL ADVISORS LLC | $18.22M | 0.00% | +685.1% |
| 8 | FMR LLC | $1.40M | 0.00% | +2.5% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of HALO with a position worth $857.32M, representing 0.01% of their portfolio. In total, 8 institutional investors hold HALO with a combined value of $2.09B.
In the most recent quarter, 1 fund opened a new position in HALO. Additionally, 4 increased their holdings and 3 reduced their positions.
Institutional investors hold $2.09B worth of HALO stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $857.32M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For HALO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their HALO positions.